Pravastatin

Details

Name
Pravastatin
Class
Other
Brand Names
Pravachol
Chemical Names
Alternate Names
Generic Names
Components
Abbreviations

Interactions

Precautionary
9
Prohibited
0
Unknown
2
Total
11
Last Updated 06-May-2020

Interactions

Showing 11 (of 11) Interactions
Precautionary

Asunaprevir/Beclabuvir/Daclatasvir (Clinical Trial)

Also known as: Asunaprevir, Beclabuvir, Daclatasvir
Anti-HCV • 1 source
Date Last Reviewed: 22-Nov-2022
View
Precautionary

Boceprevir

Also known as: Victrelis, SCH503034
Anti-HCV • 0 sources
Date Last Reviewed: 10-Jul-2018
View
Precautionary

Daclatasvir

Also known as: Daklinza, BMS-790052
Anti-HCV • 0 sources
Date Last Reviewed: 09-Jul-2018
View
Precautionary

Darunavir/Ritonavir

Also known as: Darunavir, DRV/r, Ritonavir
ARV • 1 source
Date Last Reviewed: 13-Jul-2018
View
Precautionary

Dasabuvir/Ombitasvir/Paritaprevir/Ritonavir

Also known as: Viekira , ABT-450, Dasabuvir, Ombitasvir, Paritaprevir, Ritonavir
Anti-HCV • 0 sources
Date Last Reviewed: 13-Jul-2018
View
Unknown or no reaction

Elbasvir/Grazoprevir

Also known as: Zepatier, MK-5172 , MK-8742, Elbasvir, Grazoprevir
Anti-HCV • 1 source
Date Last Reviewed: 18-Jul-2018
View
Unknown or no reaction

GS-9674 / GS-0976

Also known as: GS-9674, GS-0976
Anti-NASH • 0 sources
Date Last Reviewed: 23-Jul-2018
View
Precautionary

Glecaprevir/Pibrentasvir

Also known as: ABT-493/ABT-530, ABT-493, ABT-530, PIB, Glecaprevir, Pibrentasvir, MAVYRET
Anti-HCV • 0 sources
Date Last Reviewed: 23-Jul-2018
View
Precautionary

Ledipasvir/Tegobuvir/Vedroprevir

Also known as: Ledipasvir, Tegobuvir, Vedroprevir
Anti-HCV • 1 source
Date Last Reviewed: 22-Nov-2022
View
Precautionary

Ombitasvir/Paritaprevir/Ritonavir

Also known as: Technivie, ABT-450, Ombitasvir, Paritaprevir, Ritonavir
Anti-HCV • 1 source
Date Last Reviewed: 22-Nov-2022
View
Precautionary

Sofosbuvir/Velpatasvir/Voxilaprevir

Also known as: Sofosbuvir/Velpatasvir/GS-9857, Sofosbuvir, Velpatasvir, Voxilaprevir, GS-9857, Vosevi
Anti-HCV • 1 source
Date Last Reviewed: 20-Jul-2018
View